Professor Aziz Sheikh OBE leads the Usher Institute.
Professor Aziz Sheikh OBE, Director
Professor Sheikh is Director of the Usher Institute. He is also Director of the Asthma UK Centre for Applied Research (AUKCAR), Director of the Scottish Allergy and Respiratory Academy (SARA), Director of the NIHR Global Respiratory Health Unit (RESPIRE) and is Co-Director of the NHS Digital Academy.
Aziz is a primary care academic and epidemiologist with substantial research interests in asthma/allergy and in leveraging the potential of health information technology and data science to transform the delivery of care and improve population health.
He enjoys collaborations with academic colleagues across the globe and works closely with policymakers both in the UK and internationally.
He has held research grants in excess of $90m, publishes regularly in the world's foremost journals, has over 50,000 citations to his work and is a Highly Cited Researcher (Clarivate, 2018).
Currently Aziz holds a number of visiting chairs, namely: University of Birmingham (UK), Queen Mary’s University of London (UK) and Maastricht University (Netherlands). He was previously Visiting Professor of Medicine at Harvard Medical School.
He is an editorial board member of BMC Medicine, Health Informatics Journal, Journal of the Royal Society of Medicine, Medical Care and PLOS Medicine, and is Editor-in-Chief of npj: Primary Care Respiratory Medicine.
Aziz was made an Officer of the Order of the British Empire for Services to Medicine and Health Care by Her Majesty Queen Elizabeth II in 2014.
Professor Jackie Price, Deputy Director
Jackie Price is Professor of Molecular Epidemiology, an honorary consultant in public health medicine, NHS Lothian and Deputy Director of the Usher Institute. She is co-ordinating editor of the Cochrane Vascular Review Group, Edinburgh lead for the UK-based UCLEB Collaboration on applied genomics and Postgraduate Research Director for the Usher Institute.
Professor Price has long standing experience in many aspects of evidence-based medicine and molecular epidemiology with a particular long term interest in the vascular and non-vascular complications of type 2 diabetes. She has explored the effect of aspirin on age-related cognitive decline in people with asymptomatic atherosclerosis, in the first major clinical trial of its kind, and has developed population-based studies and biobanks in several human populations, including the Edinburgh Type 2 Diabetes Study with core funding from MRC. Recent projects have explored circulating, genetic and retinal image-based biomarkers for age-related cognitive decline, renal dysfunction, dementia, liver disease and macrovascular disease in people with type 2 diabetes, including their potential use in risk prediction. She is also a member of numerous national and international collaborations, notably on global burden of disease, asymptomatic vascular disease and -omics.
Senior Leadership Team
The Usher Institute senior leadership team includes the Heads of Centres, Directors of Research, Innovation, Education, Postgraduate Research and Knowledge Exchange, Senior Research Strategy Manager, SRO Data-Driven Innovation Hub and Director of Professional Services.